{"id":1176,"date":"2016-08-16T13:46:51","date_gmt":"2016-08-16T11:46:51","guid":{"rendered":"http:\/\/semmelweis.hu\/symposium\/?page_id=1176"},"modified":"2018-01-17T13:53:42","modified_gmt":"2018-01-17T12:53:42","slug":"tudomanyos-program","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/symposium\/szimpozium-archiv\/semmelweis-szimpozium-2016-b\/tudomanyos-program\/","title":{"rendered":"Tudom\u00e1nyos Program 2016."},"content":{"rendered":"

A Semmelweis Szimp\u00f3zium hivatalos nyelve az angol.<\/p>\n\n\n\n\n
\n

17th November<\/strong><\/p>\n<\/td>\n<\/tr>\n

Pathogenesis and molecular genetics of hematological malignancies<\/span><\/strong><\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n
13:45-
\n 14:00<\/span><\/td>\n		\n

Opening ceremony<\/strong><\/p>\n<\/td>\n<\/tr>\n

14:00-
\n 14:20<\/span><\/td>\n		\n

Jude Fitzgibbon<\/strong> (London, UK):
\n Genetic and epigenetic alterations of small B-cell lymphomas\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n

14:25-
\n 14:45<\/span><\/td>\n		\n

Csaba B\u00f6d\u00f6r\u00a0<\/b>(Budapest, Hungary):
\n The genomic landscape of chronic lymphocytic leukemia<\/span><\/p>\n<\/td>\n<\/tr>\n

14:50-
\n 15:10<\/span><\/td>\n		\n

Andr\u00e1s Matolcsy<\/b> (Budapest, Hungary):
\n Richter transformation of chronic lymphocytic leukaemia<\/span><\/p>\n<\/td>\n<\/tr>\n

15:15-
\n 15:35<\/span><\/td>\n		\n

Roland Jager<\/b> (Vienna, Austria):
\n Pathogenesis of myeloproliferative neoplasms<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\n

 <\/p>\n

15:35-16:00<\/strong><\/p>\n<\/td>\n

\n

 <\/p>\n

Coffee break<\/em><\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n
16:00-
\n 16:20<\/td>\n		\n

Leonie Saft <\/strong>(Stockholm, Sweden):
\n Novel aspects of myelodysplastic syndromes<\/span><\/p>\n<\/td>\n<\/tr>\n

16:25-
\n 16:45<\/td>\n		\n

P\u00e9ter Kir\u00e1ly<\/strong> (Budapest, Hungary):
\n Genetic predisposition to myeloid malignancies<\/span><\/p>\n<\/td>\n<\/tr>\n

16:45-
\n 17:00<\/td>\n		\n

Daniel Veres<\/strong> (Budapest, Hungary):
\n Artificial intelligence guided therapy design in oncohematology<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\n

17:00-
\n 19:00<\/p>\n<\/td>\n

\n

Poster session
\n <\/strong>2nd floor of the Department of Pathology and Experimental Cancer Research<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n
\n

 <\/p>\n

18th November<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Morning session:\u00a0
\n New trends in haematopoietic stem cell transplantation<\/span><\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n
\n

09:00-
\n 09:10<\/p>\n<\/td>\n

\n

Tam\u00e1s Masszi<\/strong> (Budapest, Hungary):
\n Introduction: Activity and history of Hungarian\u00a0 haemopoietic stem cell transplantation<\/span><\/p>\n<\/td>\n<\/tr>\n

09:15-
\n 09:35<\/td>\n		\n

Robert Gale<\/strong> (USA):
\n Lessons on haemopoietic stem cell transplantation<\/span><\/p>\n<\/td>\n<\/tr>\n

09:40-
\n 10:00<\/td>\n		\n

Francesco Dazzi<\/strong> (London, UK):
\n Mesenchymal stromal cells, biology, production and clinical use in haematology<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

10:05-
\n 10:25<\/p>\n<\/td>\n

\n

Kriszti\u00e1n N\u00e9meth <\/strong>\u00a0(Wisconsin, USA):
\n Mesenchymal stem cells and macrophages: old friends with new perspectives<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

10:30-
\n 10:50<\/p>\n<\/td>\n

\n

Eliane Gluckman<\/strong> (Paris, France):
\n Cord blood transplantation\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\n

10:50-11:10<\/strong><\/p>\n<\/td>\n

\n

Coffee break<\/em><\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n
11:10-
\n 11:20<\/td>\n		\n

Zolt\u00e1n P\u00f3s<\/strong> (Budapest, Hungary):
\n Lymphocyte homing in graft versus host disease<\/span><\/p>\n<\/td>\n<\/tr>\n

\n

11:25-
\n 11:35<\/p>\n<\/td>\n

\n

J\u00e1nos Sink\u00f3<\/strong> (Budapest, Hungary):
\n Viral infections following stem cell transplantation<\/span><\/p>\n<\/td>\n<\/tr>\n

11:40-
\n 11:50<\/td>\n		\n

Gergely Kriv\u00e1n<\/strong> (Budapest, Hungary):
\n Virus specific T-cell treatment following stem cell transplantation<\/span><\/p>\n<\/td>\n<\/tr>\n

11:55-
\n 12:05<\/td>\n		\n

Tam\u00e1s Masszi<\/strong> (Budapest, Hungary):
\n T-cell replete graft with post-transplant cyclophosphamide in haploidentical and mismatched VUD SCT<\/span><\/p>\n<\/td>\n<\/tr>\n

12:10-
\n 12:30<\/td>\n		\n

Jane Apperley<\/strong> (London, UK):
\n Cellular therapy –\u00a0 What is the future?<\/span><\/p>\n<\/td>\n<\/tr>\n

 <\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\n

Afternoon session: Multidisciplinarity in onco-hematology<\/span><\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n
14:00-
\n 14:20<\/td>\n		\n

Richard\u00a0Clark\u00a0<\/strong>(Liverpool, UK):
\n Optimal management and avoidance of adverse events of treatment in chronic myeloid leukemia<\/span><\/p>\n<\/td>\n<\/tr>\n

14:25-
\n 14:35<\/td>\n		\n

P\u00e9ter Holl\u00f3 <\/strong>(Budapest, Hungary):
\n Cutaneous side effects of molecularly targeted treatments in oncohematology<\/span><\/p>\n<\/td>\n<\/tr>\n

14:40-
\n 15:00<\/td>\n		\n

Judit Demeter<\/strong> (Budapest, Hungary):
\n Experience with low dose vemurafenib treatment in hairy cell leukemia<\/span><\/p>\n<\/td>\n<\/tr>\n

15:05-
\n 15:25:<\/td>\n		\n

Roch Houot\u00a0<\/strong>(Rennes, France):
\n Why immunooncology in hematology?<\/span><\/p>\n<\/td>\n<\/tr>\n

15:30-
\n 15:50<\/td>\n		\n

Zsolt Nagy<\/strong> (Budapest, Hungary):
\n Myeloma bone disease: from bisphosphonates to inhibitors of RANK ligand and beyond<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

A Semmelweis Szimp\u00f3zium hivatalos nyelve az angol. 17th November Pathogenesis and molecular genetics of hematological malignancies 13:45- 14:00 Opening ceremony 14:00- 14:20 Jude Fitzgibbon (London, UK): Genetic and epigenetic alterations of small B-cell lymphomas\u00a0 14:25- 14:45 Csaba B\u00f6d\u00f6r\u00a0(Budapest, Hungary): The genomic landscape of chronic lymphocytic leukemia 14:50- 15:10 Andr\u00e1s Matolcsy (Budapest, Hungary): Richter transformation of …<\/p>\n","protected":false},"author":101021,"featured_media":0,"parent":1235,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-1176","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/users\/101021"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/comments?post=1176"}],"version-history":[{"count":10,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1176\/revisions"}],"predecessor-version":[{"id":1624,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1176\/revisions\/1624"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1235"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/media?parent=1176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/categories?post=1176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/tags?post=1176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}